Literature DB >> 18056629

Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression.

Hicham Lahlou1, Virginie Sanguin-Gendreau, Dongmei Zuo, Robert D Cardiff, Gordon W McLean, Margaret C Frame, William J Muller.   

Abstract

Elevated expression and activation of the focal adhesion kinase (FAK) occurs in a large proportion of human breast cancers. Although several studies have implicated FAK as an important signaling molecule in cell culture systems, evidence supporting a role for FAK in mammary tumor progression is lacking. To directly assess the role of FAK in this process, we have used the Cre/loxP recombination system to disrupt FAK function in the mammary epithelium of a transgenic model of breast cancer. Using this approach, we demonstrate that FAK expression is required for the transition of premalignant hyperplasias to carcinomas and their subsequent metastases. This dramatic block in tumor progression was further correlated with impaired mammary epithelial proliferation. These observations provide direct evidence that FAK plays a critical role in mammary tumor progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18056629      PMCID: PMC2154426          DOI: 10.1073/pnas.0710091104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma.

Authors:  Rashna Madan; Matthew B Smolkin; Rubina Cocker; Rana Fayyad; Maja H Oktay
Journal:  Hum Pathol       Date:  2006-01       Impact factor: 3.466

2.  Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.

Authors:  Faye M Johnson; Babita Saigal; Moshe Talpaz; Nicholas J Donato
Journal:  Clin Cancer Res       Date:  2005-10-01       Impact factor: 12.531

Review 3.  Integrin-regulated FAK-Src signaling in normal and cancer cells.

Authors:  Satyajit K Mitra; David D Schlaepfer
Journal:  Curr Opin Cell Biol       Date:  2006-08-17       Impact factor: 8.382

4.  Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo.

Authors:  Ta-Jen Liu; Tiffany LaFortune; Toshiyuki Honda; Osamu Ohmori; Shinji Hatakeyama; Thomas Meyer; Dowdy Jackson; John de Groot; W K Alfred Yung
Journal:  Mol Cancer Ther       Date:  2007-04       Impact factor: 6.261

5.  Mammary epithelial-specific deletion of the focal adhesion kinase gene leads to severe lobulo-alveolar hypoplasia and secretory immaturity of the murine mammary gland.

Authors:  Tamas Nagy; Huijun Wei; Tang-Long Shen; Xu Peng; Chun-Chi Liang; Boyi Gan; Jun-Lin Guan
Journal:  J Biol Chem       Date:  2007-08-23       Impact factor: 5.157

6.  Polyethylenimine-complexed plasmid particles targeting focal adhesion kinase function as melanoma tumor therapeutics.

Authors:  Shufeng Li; Wei Dong; Yiwei Zong; Wu Yin; Guanghui Jin; Qingang Hu; Xiaofeng Huang; Wenhui Jiang; Zi-Chun Hua
Journal:  Mol Ther       Date:  2007-02-06       Impact factor: 11.454

7.  Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model.

Authors:  S K Mitra; S-T Lim; A Chi; D D Schlaepfer
Journal:  Oncogene       Date:  2006-03-20       Impact factor: 9.867

8.  Cellular characterization of a novel focal adhesion kinase inhibitor.

Authors:  Jill K Slack-Davis; Karen H Martin; Robert W Tilghman; Marcin Iwanicki; Ethan J Ung; Christopher Autry; Michael J Luzzio; Beth Cooper; John C Kath; W Gregory Roberts; J Thomas Parsons
Journal:  J Biol Chem       Date:  2007-03-28       Impact factor: 5.157

9.  Ablation of beta1 integrin in mammary epithelium reveals a key role for integrin in glandular morphogenesis and differentiation.

Authors:  Matthew J Naylor; Na Li; Julia Cheung; Emma T Lowe; Elise Lambert; Rebecca Marlow; Pengbo Wang; Franziska Schatzmann; Timothy Wintermantel; Günther Schüetz; Alan R Clarke; Ulrich Mueller; Nancy E Hynes; Charles H Streuli
Journal:  J Cell Biol       Date:  2005-11-21       Impact factor: 10.539

10.  Specific induction of pp125 focal adhesion kinase in human breast cancer.

Authors:  D O Watermann; B Gabriel; M Jäger; M Orlowska-Volk; A Hasenburg; A zur Hausen; G Gitsch; E Stickeler
Journal:  Br J Cancer       Date:  2005-09-19       Impact factor: 7.640

View more
  115 in total

1.  Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models.

Authors:  Colin Walsh; Isabelle Tanjoni; Sean Uryu; Alok Tomar; Ju-Ock Nam; Hong Luo; Angelica Phillips; Neela Patel; Cheni Kwok; Gerald McMahon; Dwayne G Stupack; David D Schlaepfer
Journal:  Cancer Biol Ther       Date:  2010-05-15       Impact factor: 4.742

2.  PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments.

Authors:  Isabelle Tanjoni; Colin Walsh; Sean Uryu; Alok Tomar; Ju-Ock Nam; Ainhoa Mielgo; Ssang-Taek Lim; Congxin Liang; Marcel Koenig; Connie Sun; Neela Patel; Cheni Kwok; Gerald McMahon; Dwayne G Stupack; David D Schlaepfer
Journal:  Cancer Biol Ther       Date:  2010-05-15       Impact factor: 4.742

Review 3.  Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression.

Authors:  Pepper Schedin; Patricia J Keely
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

Review 4.  FAK in cancer: mechanistic findings and clinical applications.

Authors:  Florian J Sulzmaier; Christine Jean; David D Schlaepfer
Journal:  Nat Rev Cancer       Date:  2014-08-07       Impact factor: 60.716

5.  CrkII transgene induces atypical mammary gland development and tumorigenesis.

Authors:  Kelly E Fathers; Sonia Rodrigues; Dongmei Zuo; Indrani Vasudeva Murthy; Michael Hallett; Robert Cardiff; Morag Park
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

6.  Collagen density regulates xenobiotic and hypoxic response of mammary epithelial cells.

Authors:  Colleen S Curran; Esteban R Carrillo; Suzanne M Ponik; Patricia J Keely
Journal:  Environ Toxicol Pharmacol       Date:  2014-11-01       Impact factor: 4.860

7.  Function of focal adhesion kinase scaffolding to mediate endophilin A2 phosphorylation promotes epithelial-mesenchymal transition and mammary cancer stem cell activities in vivo.

Authors:  Huaping Fan; Xiaofeng Zhao; Shaogang Sun; Ming Luo; Jun-Lin Guan
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

Review 8.  Bi-directional signaling: extracellular matrix and integrin regulation of breast tumor progression.

Authors:  Scott Gehler; Suzanne M Ponik; Kristin M Riching; Patricia J Keely
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2013       Impact factor: 1.807

9.  Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells.

Authors:  Ming Luo; Huaping Fan; Tamas Nagy; Huijun Wei; Chenran Wang; Suling Liu; Max S Wicha; Jun-Lin Guan
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

10.  Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling.

Authors:  Yuliya Pylayeva; Kelly M Gillen; William Gerald; Hilary E Beggs; Louis F Reichardt; Filippo G Giancotti
Journal:  J Clin Invest       Date:  2009-01-19       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.